Navigation Links
China PharmaHub Signs Agreement with Chengdu Yongkon Pharmacy
Date:8/18/2010

BOSTON, Aug. 18 /PRNewswire/ -- China PharmaHub Corp. ("PharmaHub"), recently merged with World Wide Relics (OTC Bulletin Board: WRLC), which will be shortly changing its name to China PharmaHub Corp, is proud to announce it has signed a cooperation agreement with Chengdu Yongkon Pharmacy Co. Ltd., ("Yongkon"), a pharmaceutical company based in Sichuan, with an established sales network of over 2600 hospitals in China.  PharmaHub was authorized by Yongkon as its appointed agent to identify pharmaceutical products and medical devices in the U.S. and negotiate the terms to obtain the rights to sell such products and devices in China.

Yongkon is an established and GMP certified pharmaceutical company with focus on the identification, development, manufacture, sales and distribution of Chinese traditional medicine, biopharmaceuticals and medical equipment with its focus on antiviral drugs, bio-engineering drugs and anticancer drugs.  Yongkon manufactures and sells over 90 GMP approved drugs in China. Its leading product, Xiaojinwan, is a well known Traditional Chinese Medicine treating breast hyperplasia, thyroid and benign tumor.  Yongkon has a marketing force of over 400 sales personnel in 34 sales offices in over 31 provinces and cities as well as in Beijing, Tianjin, Shanghai and Chongqing.  

Richard Lui, CEO of PharmaHub, said "We are glad to gain another capable strategic partner in China. In less than one year of founding, we have successfully established partnerships with Research Institute and Government Agencies in China. We have now taken an important step in the partnership with entrepreneurs.  With the accomplishment of this major milestone, we've successfully created a chain of command in the commercialization of technologies we identify and bring to China.  Yongkon supports our structure with an established sales and marketing team and nationwide sales channel."

Lui continued, "This is another successful demonstration of our HUB model, of partnering with successful enterprises and working together to bring life saving pharmaceuticals and medical devices to the world.  PharmaHub's relationships with the New Drug Center and the Sichuan Technical Exchange Center, and now with Chengdu Yongkon, represent PharmaHub's drive to become  an innovator in the pharmaceutical and medical device industry."

About PharmaHub:China PharmaHub Corp. is engaged in the business of licensing, developing and the commercialization of pharmaceutical and healthcare products and technologies between Chinese pharmaceutical companies and other pharmaceutical companies located worldwide, with initial emphasis in the United States and Europe. Management believes that PharmaHub brings a unique wealth of resources to assist scientists and companies in bringing their ideas to reality.  PharmaHub's corporate headquarters are located in California, with offices in Boston and China. For more information visit www.chnpharmahub.com .Contact:Monica DingChief Financial OfficerTel: (909) 843-6288Email: ir@chnpharmahub.com Forward-Looking StatementsThis press release, together with other statements and information publicly disseminated by the Company, contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. The Company intends such forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995 and includes this statement for purposes of complying with these safe harbor provisions. Except as otherwise required by the federal securities laws, the Company disclaims any obligation or undertaking to publicly release any updates or revisions to any forward-looking statement contained herein.


'/>"/>

SOURCE China PharmaHub Corp.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. New Report - Telemedicine Market in Brazil, Russia, India, China (BRIC) - Advanced Technologies, Global Forecast by MarketsandMarkets
2. China Ruitai International Holdings Co., Ltd. Reports Financial Results for the Second Quarter 2010
3. Varian Medical Systems to Showcase Advanced Motion Management Technology for the Treatment of Lung Cancer at CHINA-HOSPEQ 2010
4. China Medical Technologies Reports First Fiscal Quarter Financial Results
5. China Nepstar Chain Drugstore Reports One-time Non-recurring Penalty Payment
6. China Pharma Holdings, Inc. to Report Second Quarter 2010 Financial Results on August 10, 2010
7. Winner Medical Launches Its First Online PurCotton(R) Store in China on Taobao.com
8. FINRA Confirms China BCTs Corporate Name Change
9. China Sky One Medical Obtains SFDA Approval for Ciclopirox Olamine Vaginal Suppositories
10. China Yongxin Pharmaceuticals Inc. Announces the Expansion of Its Chain of Retail Stores to 110 Stores
11. China Nepstar Chain Drugstore Provides Updates on Shoppers Card Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2017)... Hill-Rom Holdings, Inc. ("Hill-Rom") (NYSE: HRC), today ... June 30, 2017, and updated its financial outlook for ... For the fiscal third quarter, Hill-Rom reported earnings of ... share in the prior-year period. These results reflect after-tax ... share primarily related to the non-cash write-down of assets ...
(Date:7/27/2017)... Pa., July 27, 2017  West Pharmaceutical Services, Inc. ... results for the second-quarter 2017 and updated financial guidance ... Second-Quarter 2017 Highlights Reported net ... over the prior-year quarter. Net sales at constant currency ... reported-diluted EPS was $0.51, compared to $0.60 in the ...
(Date:7/26/2017)... , July 26, 2017 Sancilio Pharmaceuticals Company, ... our clinical trial evaluating Altemia TM , an oral ... and Sickle Cell Disease (SCD). The SCOT Trial, is ... efficacy and safety of Altemia TM in pediatric ... under US IND 125274. ...
Breaking Medicine Technology:
(Date:8/16/2017)... Lewisville, TX (PRWEB) , ... August 16, 2017 , ... ... in the United States, named Dr. Douglas J. Harrison, as the new Medical Director ... will be the new facility Medical Director of our Sienna Plantation location,” said Dr. ...
(Date:8/16/2017)... ... , ... “God Will Break Every Chain”: an inspirational story for those shackled by the chains ... author, Evangelist Joann Shivers, a writer and a woman of great faith and wisdom. ... early age. She was born and raised in Vero Beach, Florida and has dedicated ...
(Date:8/15/2017)... ... August 15, 2017 , ... The first study to ... multiple myeloma has been completed, with the team’s findings now published online ahead of ... , Director of the Blood and Marrow Transplant Program at Roswell Park Cancer Institute, ...
(Date:8/15/2017)... ... August 15, 2017 , ... Progressive Dental, a leading ... on the 2017 Fast 50 list of Fastest Growing Companies in Tampa Bay. The ... area who has shown three consecutive years of growth. For this year’s award, Progressive ...
(Date:8/15/2017)... ... August 15, 2017 , ... Dr. Timothy Davis ... periodontal disease . This information can be used to develop patient-specific treatment ... The two salivary diagnostic tests, named MyPerioPath® and MyPerioID® are offered by OralDNA® ...
Breaking Medicine News(10 mins):